The interim analysis of a single-arm, open-label, phase II study investigating ALLEN regimen (durvalumab plus albumin paclitaxel and lenvatinib) in patients with unresectable biliary tract cancers ...
Efficacy and safety of surufatinib combined with immune checkpoint inhibitors plus chemotherapy in patients with biliary tract cancers: A real-world study. This is an ASCO Meeting Abstract from the ...
Transarterial chemoembolization (TACE) is the standard locoregional treatment for patients with unresectable primary liver cancer, particularly hepatocellular carcinoma (HCC). While advances in ...
Embolization is an effective approach for the management of HCC with noncurative options. However, it has several limitations, with reduced efficacy for large tumors. Multimodal treatments are being ...
Transarterial chemoembolization (TACE) is a type of treatment for liver cancer. It works by delivering chemotherapy drugs directly to the tumor and blocking its blood supply. Liver cancer occurs when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results